Vaginal cytokines in normal pregnancy - PubMed (original) (raw)
Vaginal cytokines in normal pregnancy
Gilbert G G Donders et al. Am J Obstet Gynecol. 2003 Nov.
Abstract
Objective: The purpose of this study was to determine whether the vaginal cytokine concentration varies during the course of uncomplicated pregnancy.
Study design: Prenatal visits of healthy women to University Hospital Gasthuisberg, Leuven, Belgium were considered. Cytokine levels in vaginal washings from 30 unselected healthy women with uncomplicated pregnancies were monitored during pregnancy and compared with those from 62 nonpregnant healthy control subjects. Exclusion criteria included bacterial vaginosis, moderate or severe aerobic vaginitis, Trichomonas vaginalis, Candida vaginitis (wet mount or culture), gonorrhea, and Chlamydia. Interleukin-6, interleukin-8, interleukin-1beta, interleukin-1-receptor antagonist, leukemia inhibitory factor, and tumor necrosis factor were measured. Nonparametric Kruskal-Wallis and Welch tests were used for univariate analysis, and the Spearman rank test was used for multivariate analysis.
Results: Compared with concentrations in nonpregnant women, interleukin-1beta concentrations were similar, but interleukin-1-receptor antagonist production was depressed throughout pregnancy. Vaginal interleukin-6 and interleukin-8 were less often discovered during pregnancy than outside pregnancy and dipped significantly in the middle trimester, to rise again to prepregnancy levels in the third trimester. Leukemia inhibitory factor was lower during the beginning of pregnancy (P=.038) but otherwise did not differ from nonpregnant values throughout pregnancy nor did tumor necrosis factor. Sexual activity could not explain these findings.
Conclusion: Vaginal cytokine levels, especially interleukin-1 receptor antagonist, from pregnant women may differ from nonpregnant values; some levels, such as interleukin-6 and interleukin-8, may fluctuate during normal pregnancy. These spontaneous variations during pregnancy must be taken into account when mucosal immunologic responses to infection of the lower genital tract are being studied.
Similar articles
- Pathogenesis of abnormal vaginal bacterial flora.
Donders GG, Bosmans E, Dekeersmaecker A, Vereecken A, Van Bulck B, Spitz B. Donders GG, et al. Am J Obstet Gynecol. 2000 Apr;182(4):872-8. doi: 10.1016/s0002-9378(00)70338-3. Am J Obstet Gynecol. 2000. PMID: 10764465 - Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis.
Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Donders GG, et al. BJOG. 2002 Jan;109(1):34-43. doi: 10.1111/j.1471-0528.2002.00432.x. BJOG. 2002. PMID: 11845812 - Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth.
Genc MR, Onderdonk AB, Vardhana S, Delaney ML, Norwitz ER, Tuomala RE, Paraskevas LR, Witkin SS; MAP Study Group. Genc MR, et al. Am J Obstet Gynecol. 2004 Oct;191(4):1324-30. doi: 10.1016/j.ajog.2004.05.074. Am J Obstet Gynecol. 2004. PMID: 15507961 - Association between vaginal 70-kd heat shock protein, interleukin-1 receptor antagonist, and microbial flora in mid trimester pregnant women.
Genç MR, Karaşahin E, Onderdonk AB, Bongiovanni AM, Delaney ML, Witkin SS; Microbiology and Prematurity Study Group. Genç MR, et al. Am J Obstet Gynecol. 2005 Mar;192(3):916-21. doi: 10.1016/j.ajog.2004.09.023. Am J Obstet Gynecol. 2005. PMID: 15746691 - Factors affecting decidual IGFBP-1 levels in the vagina and cervix in the first and mid-second trimester of pregnancy.
Rahkonen L, Unkila-Kallio L, Rutanen EM, Paavonen J. Rahkonen L, et al. BJOG. 2009 Jan;116(1):45-54. doi: 10.1111/j.1471-0528.2008.01959.x. Epub 2008 Nov 11. BJOG. 2009. PMID: 19016684
Cited by
- Cracking the Code: Investigating the Correlation between Aerobic Vaginitis and Preterm Labor.
Zarmakoupi P, Psarris A, Karasmani C, Antsaklis P, Theodora M, Syndos M, Pampanos A, Pappa KI, Domali E, Thomakos N, Akinosoglou K, Tsiakalos A, Daskalakis G. Zarmakoupi P, et al. Medicina (Kaunas). 2024 Apr 18;60(4):648. doi: 10.3390/medicina60040648. Medicina (Kaunas). 2024. PMID: 38674294 Free PMC article. Review. - DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy.
Bunge K, Balkus JE, Fairlie L, Mayo AJ, Nakabiito C, Mgodi N, Gadama L, Matrimbira M, Chappell CA, Piper J, Chakhtoura N, Szydlo DW, Richardson B, Hillier SL. Bunge K, et al. J Acquir Immune Defic Syndr. 2024 Jan 1;95(1):65-73. doi: 10.1097/QAI.0000000000003312. J Acquir Immune Defic Syndr. 2024. PMID: 38055292 Clinical Trial. - Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities.
Redelinghuys MJ, Geldenhuys J, Jung H, Kock MM. Redelinghuys MJ, et al. Front Cell Infect Microbiol. 2020 Aug 11;10:354. doi: 10.3389/fcimb.2020.00354. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32850469 Free PMC article. Review. - Repeated Measures of Cervicovaginal Cytokines during Healthy Pregnancy: Understanding "Normal" Inflammation to Inform Future Screening.
Buxton MA, Meraz-Cruz N, Sánchez BN, Foxman B, Gronlund CJ, Beltran-Montoya J, Castillo-Castrejon M, O'Neill MS, Vadillo-Ortega F. Buxton MA, et al. Am J Perinatol. 2020 May;37(6):613-620. doi: 10.1055/s-0039-1685491. Epub 2019 Apr 12. Am J Perinatol. 2020. PMID: 30978743 Free PMC article. - Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners.
Thomson KA, Hughes J, Baeten JM, John-Stewart G, Celum C, Cohen CR, Ngure K, Kiarie J, Mugo N, Heffron R; Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams. Thomson KA, et al. J Infect Dis. 2018 Jun 5;218(1):16-25. doi: 10.1093/infdis/jiy113. J Infect Dis. 2018. PMID: 29514254 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical